PlainRecalls
FDA Drug Moderate Class II Ongoing

Glenmark, Azelaic Acid Gel, 15 %, 50 grams, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa, 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52.

Reported: August 7, 2024 Initiated: July 22, 2024 #D-0621-2024

Product Description

Glenmark, Azelaic Acid Gel, 15 %, 50 grams, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa, 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52.

Reason for Recall

CGMP Deviations

Details

Units Affected
14,004 cartons
Distribution
U.S. Nationwide
Location
Mahwah, NJ

Frequently Asked Questions

What product was recalled?
Glenmark, Azelaic Acid Gel, 15 %, 50 grams, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa, 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52.. Recalled by Glenmark Pharmaceuticals Inc., USA. Units affected: 14,004 cartons.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on August 7, 2024. Severity: Moderate. Recall number: D-0621-2024.